While GLP-1s go after the energy input side of the equation, Rivus is targeting the energy expenditure side, Khan said, adding that this approach is more sustainable
Nutrition, metabolism, and cardiovascular diseases: NMCD
Weight Loss Drug Comparison: Efficacy, Muscle Loss, and Market Stage Towards a Dual-Action Approach: Fat Loss and Muscle Preservation Recognizing the need for a more balanced approach to weight management, pharmaceutical innovators are now focusing on therapies that not only promote fat loss but also preserve or enhance muscle mass (Rodgers and Christopher 2022)
If policymakers want to expand GLP-1 coverage to include the obesity indication in Medicare, Medicaid, or the commercial insurance sector, theyll need a strategy for managing utilization and targeting populations most likely to benefit
The weight change is largely attributable to urinary glucose excretion and mild fluid loss, rather than to a direct appetite-suppressing or fat-targeting mechanism
Same-day appointments are often available either way